AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
RIFAXIMINE
9 registrations across 3 African markets— 3 active
Markets with RIFAXIMINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DIARIX Comprimé pelliculé / 200 mg | 🇹🇳Tunisia | GALPHARMA | expired | Jun 2019 |
| RIFIXINE 200 Comprimé pelliculé / 200 mg | 🇹🇳Tunisia | TAHA PHARMA | expired | Apr 2017 |
| DIARIX Comprimé pelliculé / 200 mg | 🇹🇳Tunisia | GALPHARMA | expired | Jul 2015 |
| RIFIXINE 200 Comprimé pelliculé / 200 mg | 🇹🇳Tunisia | TAHA PHARMA | expired | Jan 2015 |
| NORMIX Comprime enrobé / 200 MG | 🇹🇳Tunisia | ALFASIGMA S.p.A. | expired | Nov 2001 |
| NORMIX Suspension buvable / 2 % | 🇹🇳Tunisia | ALFASIGMA S.p.A. | expired | Nov 2001 |
| RIFIXINE comprimé pelliculé / 200 mg | 🇸🇳Senegal | TAHA PHARMA | active | — |
| NORMIX comprimé pelliculé / 200 mg | 🇸🇳Senegal | ALFA ASSERMANN | active | — |
| NORMIX 200MG COMPRIME BOITE DE 12 | 🇨🇮Côte d'Ivoire | ALFASIGMA S.P.A | active | — |
RIFAXIMINE in Africa — Regulatory Overview
RIFAXIMINE is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Senegal, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 3 (33%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.